PHARMACOKINETICS OF CHLORAMBUCIL IN MAN AFTER ADMINISTRATION OF THE FREE DRUG AND ITS PREDNISOLONE ESTER (PREDNIMUSTINE, LEO-1031)

被引：25

作者：

EHRSSON, H ^{[1
]}

WALLIN, I ^{[1
]}

NILSSON, SO ^{[1
]}

JOHANSSON, B ^{[1
]}

机构：

[1] KAROLINSKA HOSP,DEPT ONCOL,S-10401 STOCKHOLM 60,SWEDEN

来源：

关键词：

D O I：

10.1007/BF00613827

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：251 / 253

页数：3

共 16 条

[1] EHRSSON H, 1979, CLIN PHARMACOL THER, V25, P167
[2] EHRSSON H, 1980, J PHARM SCI, V69, P710, DOI 10.1002/jps.2600690627
[3] FORSHELL GP, 1981, UPJLEO10312797 INT R
[4] GUNNARSSON PO, 1980, UPJLEO10312583 INT R
[5] JAKHAMMER T, 1977, ACTA PHARM SUEC, V14, P485
[6] JOHNSSON JE, 1979, CANCER TREAT REP, V63, P421
[7] SOME METABOLIC ASPECTS OF A NITROGEN-MUSTARD OF PREDNISOLONE
KIRDANI, RY
MURPHY, GP
SANDBERG, AA
[J]. ONCOLOGY, 1978, 35 (02) : 47 - 53
[8] PRELIMINARY CLINICAL AND ABSORPTION STUDIES WITH PREDNIMUSTINE IN PATIENTS WITH MAMMARY-CARCINOMA
KONYVES, I
NORDENSKJOLD, B
FORSHELL, GP
DESCHRYVER, A
WESTERBERGLARSSON, H
[J]. EUROPEAN JOURNAL OF CANCER, 1975, 11 (12) : 841 - 844
[9] KONYVES I, 1973, ANTINEOPLASTIC CHEMO, P791
[10] LUND B, 1976, CLIN PHARMACOL THER, V19, P587